Full text
Earnings transcript
Read the complete earnings call transcript.
ABEV
Ambev S.A.
$3.12
0.05
(1.63%)
| Exchange: | NYSE |
| Market Cap: | 48.662B |
| Shares Outstanding: | 10.551B |
Delayed data
About The Company
| Sector: | Consumer Defensive | |||||
| Industry: | Beverages – Alcoholic | |||||
| CEO: | Carlos Eduardo Klutzenschell Lisboa | |||||
| Full Time Employees: | 43000 | |||||
| Address: |
| |||||
| Website: | https://www.ambev.com.br |
Ambev S.A., operating through its various subsidiaries, is a prominent player in the beverage and food industry across the Americas. The company is engaged in the manufacturing, marketing, and distribution of a diverse portfolio of products, including various types of beer (both packaged and on tap), carbonated soft drinks, other non-alcoholic beverages, malt, and food items. Its extensive operations are structured into four primary geographical divisions: Brazil; Central America and the Caribbean; Latin America South; and Canada. Ambev’s vast selection of beer labels features widely recognized names such as Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Bud Light, Beck, Leffe, Hoegaarden, Bucanero, Cristal, Mayabe, Cacique, Presidente, Brahma Light, Presidente Light, Presidente Golden Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Budweiser, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith’s, and Kokanee. Beyond alcoholic offerings, the company also provides a comprehensive range of non-alcoholic drinks. These include bottled water, isotonic and energy beverages, coconut water, powdered and natural fruit juices, and ready-to-drink teas. These products are sold under popular brands like Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi, Canada Dry, Squirt, Red Rock, Pepsi-Cola, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike’s. Products are made available to consumers through a multifaceted distribution approach, combining its own direct distribution network with a system that leverages third-party distributors. Ambev S.A. was founded in 1885 and maintains its corporate headquarters in São Paulo, Brazil. It operates as a subsidiary of Interbrew International B.V.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 79,736,900 | 89,452,700 | 88,242,500 |
| Gross Profit | 40,445,300 | 45,837,600 | 45,378,400 |
| EBITDA | 24,269,500 | 29,011,900 | 28,974,500 |
| Operating Income | 18,831,000 | 21,801,700 | 22,322,600 |
| Net Income | 14,501,900 | 14,437,200 | 15,503,400 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 132,644,300 | 162,507,949 | 148,112,684 |
| Total Liabilities | 52,500,500 | 62,927,435 | 59,337,903 |
| Total Stockholders Equity | 78,969,290 | 98,642,139 | 87,914,039 |
| Total Debt | 3,501,100 | 3,452,700 | 5,349,586 |
| Cash and Cash Equivalents | 16,059,000 | 28,595,700 | 18,638,228 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 24,711,400 | 26,099,035 | 24,450,283 |
| Capital Expenditure | -6,004,100 | -4,749,101 | -4,590,474 |
| Free Cash Flow | 18,707,300 | 21,349,934 | 19,859,809 |
| Net Income | 14,501,944 | 14,437,238 | 15,503,400 |
| Net Change in Cash | 1,206,900 | 12,536,663 | -9,957,438 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 114,770,057.379 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 122,104,025.141 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 118,954,972.027 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 35,230,157.144 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 37,481,413.636 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 36,514,770.954 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 25,398,617.537 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 27,531,780.832 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 26,615,842.766 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 33,844,127.796 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 36,006,815.067 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 35,078,202.165 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 1.700 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 1.760 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 1.620 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 7 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 2 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Financial Performance: Ambev reported strong financial results in the Q4 2024 earnings call, with notable growth in revenue and net income, underpinned by effective cost management and operational efficiency. Key metrics such as EBITDA and operating income reflect a solid profitability profile, as highlighted in the earnings call summary.
- Strong Brand Portfolio: The company’s emphasis on leveraging its brand portfolio, as mentioned in the Q4 2024 earnings call, positions it favorably within the competitive beverage industry. This strength is supported by consistent gross profit margins (per Key Metrics TTM data) and diversified revenue streams across product categories (per Revenue Product Segments).
- Positive Cash Flow Generation: Ambev demonstrates healthy cash flow metrics, with significant net cash provided by operating activities and positive free cash flow (per Cash Flow Statements). This financial stability supports reinvestment and dividend payouts, as evidenced by the dividend yield (per Key Metrics TTM).
- Market Leadership in Key Regions: Revenue distribution across geographic segments (per Revenue Geo Segments) indicates a strong foothold in core markets, contributing to sustained revenue growth and resilience against localized economic downturns.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about ABEV valuation
Is Ambev S.A. (ABEV) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Ambev S.A. (ABEV) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is ABEV a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ABEV trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is ABEV’s P/E ratio?
You can see ABEV’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for ABEV?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is ABEV a good long-term investment?
Whether ABEV fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
ABEV
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
1.63
Trading Metrics:
| Open: | 3.13 | Previous Close: | 3.07 | |
| Day Low: | 3.1 | Day High: | 3.15 | |
| Year Low: | 2.1 | Year High: | 3.45 | |
| Price Avg 50: | 3.1 | Price Avg 200: | 2.68 | |
| Volume: | 26.689M | Average Volume: | 27.651M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeABEV full analysis
Hey everyone, welcome back to the channel! Today, we’re diving deep into a comprehensive analysis of Ambev S.A., ticker symbol ABEV, one of the giants in the global beverage industry. If you’re curious about whether this stock deserves a spot in your portfolio, stick around because we’re breaking down everything from financials to valuation, SWOT analysis, and more. Let’s get started! First off, let’s set the stage. Ambev is a powerhouse in the beer and beverage market, with a massive…
